Butamirate
From Wikipedia, the free encyclopedia
 |
|
|
Butamirate
|
|
| Systematic (IUPAC) name | |
| 2-(2-diethylaminoethoxy)ethyl 2-phenylbutanoate | |
| Identifiers | |
| CAS number | |
| ATC code | R05 |
| PubChem | |
| Chemical data | |
| Formula | C18H29NO3 |
| Mol. mass | 307.428 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 98% |
| Metabolism | ? |
| Half life | 6 hours |
| Excretion | 90% renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Butamirate (or brospamin) is a non-opioid central cough suppressant. It acts on the cough center in the medulla oblongata. It does not cause respiratory suppression, so should be safer than codeine.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||
